Assessing paraclinical measures of axonal degeneration following acute optic neuritis

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Multiple Sclerosis (MS) is caused by immune attack on the central nervous system (CNS), resulting in loss of the insulating material that surrounds nerve cells, as well as a degree of loss of the nerve cells themselves. Several partially effective therapies are available. A hurdle in developing CNS based therapies is methods to adequately test them. This study aims to assess biomarkers that could potentially be used to measure the damage in the optic nerve, a commonly affected structure in MS.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $367,450.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Neurology and Neuromuscular Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

early detection | magnetic resonance imaging (MRI) | multiple sclerosis (MS) | neuroprotection | ophthalmology | optic neuritis